| Su-jean Seo, MD, PHD | |
|
330 Brookline Ave, Beth Israel Deaconess Medical Center, Shapiro 2, Boston, MA 02215-5400 | |
| (617) 667-3753 | |
| Not Available |
| Full Name | Su-jean Seo |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 21 Years |
| Location | 330 Brookline Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346376050 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | 231315 (Massachusetts) | Secondary |
| 207N00000X | Dermatology | 231315 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brown Dermatology Inc | 3870872773 | 27 |
News Archive
Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031'') and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm.
The International Dairy Federation (IDF), the Food and Agriculture Organization of the United Nations (FAO) and the International Farm Comparison Network (IFCN) have developed, in partnership and with support from the animal feed industry, a world map of animal feeding systems in the dairy sector. The first results will be presented at the Sustainable Feed Security Conference at the IDF World Dairy Summit, on 18 October 2011.
The adaptive immune system can recognize and respond specifically to particular infectious agents. But the first line of defence against pathogens is the so-called innate immune system. This system reacts to invaders by initiating unspecific inflammatory responses which attract various types of specialized cells such as neutrophils to the site of the incursion.
Research led by a team at Women & Infants Hospital of Rhode Island and The Warren Alpert Medical School of Brown University has been published in the February 10, 2014 online edition of Pediatrics, the official journal of the American Academy of Pediatrics.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
› Verified 1 days ago
| Entity Name | Brown Dermatology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730538026 PECOS PAC ID: 3870872773 Enrollment ID: O20161117000508 |
News Archive
Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031'') and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm.
The International Dairy Federation (IDF), the Food and Agriculture Organization of the United Nations (FAO) and the International Farm Comparison Network (IFCN) have developed, in partnership and with support from the animal feed industry, a world map of animal feeding systems in the dairy sector. The first results will be presented at the Sustainable Feed Security Conference at the IDF World Dairy Summit, on 18 October 2011.
The adaptive immune system can recognize and respond specifically to particular infectious agents. But the first line of defence against pathogens is the so-called innate immune system. This system reacts to invaders by initiating unspecific inflammatory responses which attract various types of specialized cells such as neutrophils to the site of the incursion.
Research led by a team at Women & Infants Hospital of Rhode Island and The Warren Alpert Medical School of Brown University has been published in the February 10, 2014 online edition of Pediatrics, the official journal of the American Academy of Pediatrics.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Su-jean Seo, MD, PHD 330 Brookline Ave, Beth Israel Deaconess Medical Center, Shapiro 2, Boston, MA 02215-5400 Ph: (617) 667-3753 | Su-jean Seo, MD, PHD 330 Brookline Ave, Beth Israel Deaconess Medical Center, Shapiro 2, Boston, MA 02215-5400 Ph: (617) 667-3753 |
News Archive
Invatec, a comprehensive innovator of interventional products, today introduced FiberNet®, a 3-dimensional distal Embolic Protection System (EPS) for Carotid Artery Stenting with the lowest crossing profile (0.031'') and highest performance capabilities on the market, manufactured by Lumen Biomedical. FiberNet provides superior deliverability and can be used in vessels ranging from 3.5 to 7 mm.
The International Dairy Federation (IDF), the Food and Agriculture Organization of the United Nations (FAO) and the International Farm Comparison Network (IFCN) have developed, in partnership and with support from the animal feed industry, a world map of animal feeding systems in the dairy sector. The first results will be presented at the Sustainable Feed Security Conference at the IDF World Dairy Summit, on 18 October 2011.
The adaptive immune system can recognize and respond specifically to particular infectious agents. But the first line of defence against pathogens is the so-called innate immune system. This system reacts to invaders by initiating unspecific inflammatory responses which attract various types of specialized cells such as neutrophils to the site of the incursion.
Research led by a team at Women & Infants Hospital of Rhode Island and The Warren Alpert Medical School of Brown University has been published in the February 10, 2014 online edition of Pediatrics, the official journal of the American Academy of Pediatrics.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
› Verified 1 days ago
Erica Dommasch, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Shapiro 2, Boston, MA 02215 Phone: 617-667-3753 | |
Dr. Chantal Louise Cotter, MB BCH BAO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
Dr. John J Croke, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Debjani Sahni, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany Street, Shapiro 8, Boston, MA 02118 Phone: 617-638-7420 Fax: 617-638-7289 | |
Dr. Joseph C Kvedar, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Staniford St, Suite 200, Boston, MA 02114 Phone: 617-726-2914 Fax: 617-724-2135 | |
Ryan Char Kelm, Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St # 250, Boston, MA 02114 Phone: 617-724-6960 | |
Dr. David Attar Hashemi, MD, MBA Dermatology Medicare: Medicare Enrolled Practice Location: 50 Staniford St, Boston, MA 02114 Phone: 617-726-2914 |